Clinical Protocol 1 from Safety and Clinical Outcomes of a First-in-Human Trial of Point-of-Care Manufactured Trispecific CAR T Cells Targeting CD19, CD20, and CD22
Year: 2026
Type: other
Abstract: Clinical Protocol file.
Authors: Sumithira Vasu, Nathan Denlinger, No-Joon Song, Danielle Elsberry, Qiuhong Zhao, Lianbo Yu, Evandro D. Bezerra, Nicole Szuminski, Dina Schneider, Pradyot Dash, Louisa Wirthlin, Narendranath Epperla, Yazeed Sawalha, Jennifer A. Woyach, Shamama Nishat, Kerry A. Rogers, Seema A. Bhat, Hazem E. Ghoneim, Gregory K. Behbehani, Timothy J. Voorhees, Karilyn Larkin, Adam S. Kittai, Victoria Churchill, Elizabeth George, Margaret Lamb, Dean A. Lee, Wing Keung Chan, Ashley Krull, Rimas J. Orentas, Lynn O’Donnell, Zihai Li, Lapo Alinari, Marcos de Lima
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W7207680932